Stay updated on Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a new version, changing from Revision v2.15.2 to v2.16.0.
    Difference
    0.4%
    Check dated 2025-05-22T21:14:56.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-05-01T05:05:59.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version of a clinical study on pancreatic adenocarcinoma, with significant changes in the study's description and criteria for participation. The principal investigator's name remains the same, but some details about the study's methodology and inclusion/exclusion criteria have been removed.
    Difference
    16%
    Check dated 2025-04-16T14:39:10.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 25, 2025.
    Difference
    0.4%
    Check dated 2025-04-09T09:32:49.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    The webpage has updated its dates, removing older ones and adding new ones for 2025, along with a new plan regarding Individual Participant Data (IPD).
    Difference
    3%
    Check dated 2025-03-04T02:29:44.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    2%
    Check dated 2025-02-24T21:17:38.000Z thumbnail image

Stay in the know with updates to Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial page.